Corneal cross-linking (CXL) is a treatment that strengthens the cornea — the clear, dome-shaped surface at the front of the eye. In conditions such as keratoconus, the cornea becomes thin and weak, causing it to bulge outward into a cone shape. This leads to blurred or distorted vision that glasses or contact lenses cannot fully correct.
Cross-linking uses a special combination of vitamin B (riboflavin) eye drops and ultraviolet (UV-A) light to make the cornea stronger and more stable, preventing it from getting thinner or changing shape further.
How the Procedure Works
1. Riboflavin (vitamin B ) drops are applied to the surface of the cornea.
2. The cornea is then exposed to gentle UV-A light for about 20–30 minutes.
3. The light activates the riboflavin, creating new chemical bonds (cross-links) between the collagen fibers in the cornea.
These new bonds make the cornea stronger and more resistant to deformation.
Benefits for Patients
Stops or slows the progression of keratoconus and other corneal ectatic disorders.
May slightly improve vision and make contact lenses fit better.
Reduces or delays the need for a corneal transplant.
Provides long-term stability and preservation of vision.
What Patients Should Know
Some temporary discomfort, blurred vision, or light sensitivity is normal after the procedure.
Vision typically stabilizes or improves over the following weeks to months.
The procedure is considered safe and effective when performed by an experienced ophthalmologist.
Summary
Corneal cross-linking is a modern, minimally invasive treatment that helps preserve your vision by reinforcing the cornea’s natural structure. It offers lasting protection against further vision loss in patients with keratoconus and related conditions.
At our ophthalmology clinic, we understand the importance of accessible and efficient eye care services
